RBM45 and glioblastoma: Recent studies have shown that the m6A binding protein RBM45 is required for NB cell differentiation [29], and in cancer stem cells generated from glioblastoma patients, PDGFR (platelet-derived growth factor receptor) activity exhibits enhanced m6A methylation, which encourages cell maintenance through control of mitophagy [30].